Edward P. Feener, Chief Scientific Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 4,958 shares at $8.23 ($41K) on 2023-11-20, disclosed to the SEC on 2023-11-21.
Seasonal sale ($41k) by Chief Scientific Officer — this insider has traded KALV in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| KALV | SELL | 2024-02-16 | $846K | — | Filing → |
| KALV | SELL | 2024-01-12 | $591K | — | Filing → |
| KALV | SELL | 2024-01-10 | $449K | — | Filing → |